Meanwhile, we will further explore the specific regulatory mechanisms of key genes (e.g., BDNF, DLAT, YWHAZ, and ECI2) in the progression of IDD and evaluate the feasibility of these genes as potential therapeutic targets in combination with drug screening techniques. Here, YWHAZ is linked to intervertebral disk degenerative disorder.